A 20-year-old HIV-positive adult on antiretroviral therapy (ART) in the U.S. or Canada may be expected to live into their early 70's, a life expectancy approaching that of the general population, according to results published December 18, 2013, in the open access journal PLOS ONE by Hasina Samji and colleagues from the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE) and the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
The life expectancies of nearly 23,000 individuals on ART were calculated based on mortality rates in the early to mid-2000s. Participants in the study were from the NA-ACCORD and aged 20 years or older. Changes in life expectancy from 2000 to 2007 among HIV-positive individuals were then evaluated by selected sociodemographic and clinical characteristics, such as drug use history and immune cell counts
The authors found that life expectancy at age 20 increased from 36.1 to 51.4 years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, those who were non-white, and those who initiated ART with low CD4 count (a count of cells that activate the immune response) compared to those who started at a higher count. The results of this study indicate increasing longevity for individuals living with HIV in the U.S. and Canada and contribute to the growing evidence that HIV-positive people on ART have life expectancies approaching those in general populations.
Explore further: Older children with HIV may need to start treatment sooner to normalize future CD4 count
More information: Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, et al. (2013) Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada. PLoS ONE 8(12): e81355. DOI: 10.1371/journal.pone.0081355
Medical Xpress on facebook
Related Stories
Older children with HIV may need to start treatment sooner to normalize future CD4 count
Oct 29, 2013
Although younger children with HIV are at high risk of disease progression if not treated, new research published this week in PLOS Medicine indicates that they have good potential for achieving high CD4 counts (a measur ...
Treatment leads to near-normal life expectancy for people with HIV in South Africa
Apr 09, 2013
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count ...
AIDS guidelines for children may not improve death rates but may improve treatment access
Nov 19, 2013
Recent changes to World Health Organization guidelines for starting anti-AIDS drugs (antiretroviral therapy—ART) in young children are unlikely to improve death rates but may increase the numbers of children receiving ART ...
Food insecurity linked to HIV-treated drug users' deaths
May 31, 2013
Food insecurity increases the risk of death among injection drug users living with HIV/AIDS even when they are receiving life-prolonging antiretroviral therapy (ART), according to a new study involving Simon Fraser University.
Study reveals 15-year increase in life expectancy for people with HIV in UK
Oct 12, 2011
People with HIV have a 15 years longer life expectancy thanks to improved treatments over the past 13 years, according to a new study published in the British Medical Journal today.
Recommended for you
New anti-HIV drug target identified
57 minutes ago
University of Minnesota researchers have discovered a first-of-its-kind series of compounds possessing anti-human immunodeficiency virus (HIV) activity. The compounds present a new target for potential HIV drug development ...
Animal vaccine study yields insights that may advance HIV vaccine research
2 hours ago
A vaccine study in monkeys designed to identify measurable signs that the animals were protected from infection by SIV, the monkey version of HIV, as well as the mechanism of such protection has yielded numerous insights ...
Secondary conditions affect length of hospital stay and charges for HIV patients
Dec 16, 2013
A University of Arkansas researcher and her colleagues have found that secondary conditions and diseases that could become deadly significantly affect how long HIV patients stay in the hospital.
Plaque composition, immune activation explain cardiovascular risk in HIV-infected women
Dec 13, 2013
A Massachusetts General Hospital (MGH) research team has discovered a possible mechanism behind the elevated risk of cardiovascular disease in women infected with HIV, a risk even higher than that of HIV-infected men. In ...
Hemophilia and long-term HIV infection—is there a protective link?
Dec 11, 2013
People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective ...
Spanish hospital to trial new HIV treatment
Dec 09, 2013
Researchers at a Spanish hospital announced Monday they will start trials next year of a therapeutic vaccine for patients who already have HIV, the virus that causes AIDS.
User comments
© Medical Xpress 2011-2013, Science X network
A 20-year-old HIV-positive adult on antiretroviral therapy (ART) in the U.S. or Canada may be expected to live into their early 70's, a life expectancy approaching that of the general population, according to results published December 18, 2013, in the open access journal PLOS ONE by Hasina Samji and colleagues from the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE) and the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
The life expectancies of nearly 23,000 individuals on ART were calculated based on mortality rates in the early to mid-2000s. Participants in the study were from the NA-ACCORD and aged 20 years or older. Changes in life expectancy from 2000 to 2007 among HIV-positive individuals were then evaluated by selected sociodemographic and clinical characteristics, such as drug use history and immune cell counts
The authors found that life expectancy at age 20 increased from 36.1 to 51.4 years from 2000-2002 to 2006-2007. Men and women had comparable life expectancies in all periods except the last (2006-2007). Life expectancy was lower for individuals with a history of injection drug use, those who were non-white, and those who initiated ART with low CD4 count (a count of cells that activate the immune response) compared to those who started at a higher count. The results of this study indicate increasing longevity for individuals living with HIV in the U.S. and Canada and contribute to the growing evidence that HIV-positive people on ART have life expectancies approaching those in general populations.
Explore further: Older children with HIV may need to start treatment sooner to normalize future CD4 count
More information: Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, et al. (2013) Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada. PLoS ONE 8(12): e81355. DOI: 10.1371/journal.pone.0081355
Medical Xpress on facebook
Related Stories
Older children with HIV may need to start treatment sooner to normalize future CD4 count
Oct 29, 2013
Although younger children with HIV are at high risk of disease progression if not treated, new research published this week in PLOS Medicine indicates that they have good potential for achieving high CD4 counts (a measur ...
Treatment leads to near-normal life expectancy for people with HIV in South Africa
Apr 09, 2013
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count ...
AIDS guidelines for children may not improve death rates but may improve treatment access
Nov 19, 2013
Recent changes to World Health Organization guidelines for starting anti-AIDS drugs (antiretroviral therapy—ART) in young children are unlikely to improve death rates but may increase the numbers of children receiving ART ...
Food insecurity linked to HIV-treated drug users' deaths
May 31, 2013
Food insecurity increases the risk of death among injection drug users living with HIV/AIDS even when they are receiving life-prolonging antiretroviral therapy (ART), according to a new study involving Simon Fraser University.
Study reveals 15-year increase in life expectancy for people with HIV in UK
Oct 12, 2011
People with HIV have a 15 years longer life expectancy thanks to improved treatments over the past 13 years, according to a new study published in the British Medical Journal today.
Recommended for you
New anti-HIV drug target identified
57 minutes ago
University of Minnesota researchers have discovered a first-of-its-kind series of compounds possessing anti-human immunodeficiency virus (HIV) activity. The compounds present a new target for potential HIV drug development ...
Animal vaccine study yields insights that may advance HIV vaccine research
2 hours ago
A vaccine study in monkeys designed to identify measurable signs that the animals were protected from infection by SIV, the monkey version of HIV, as well as the mechanism of such protection has yielded numerous insights ...
Secondary conditions affect length of hospital stay and charges for HIV patients
Dec 16, 2013
A University of Arkansas researcher and her colleagues have found that secondary conditions and diseases that could become deadly significantly affect how long HIV patients stay in the hospital.
Plaque composition, immune activation explain cardiovascular risk in HIV-infected women
Dec 13, 2013
A Massachusetts General Hospital (MGH) research team has discovered a possible mechanism behind the elevated risk of cardiovascular disease in women infected with HIV, a risk even higher than that of HIV-infected men. In ...
Hemophilia and long-term HIV infection—is there a protective link?
Dec 11, 2013
People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective ...
Spanish hospital to trial new HIV treatment
Dec 09, 2013
Researchers at a Spanish hospital announced Monday they will start trials next year of a therapeutic vaccine for patients who already have HIV, the virus that causes AIDS.
User comments
© Medical Xpress 2011-2013, Science X network
0 comments:
Post a Comment